4th Annual Peptides Congress 2017
April 24 - 25, 2017 - London UK

Oxford Global

g.alonso@oxfordglobal.co.uk
Phone: +44 1865248455

Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics Two-day interactive conference addressing three main themes: - Recent Progress in Peptide Technologies & Manufacturing - Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery - Advances in Peptide Therapeutics Co-located with the 10th Annual Proteins & Antibodies Congress, the event will have 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as updates in peptide stabilisation and efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed. Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as diabetes, metabolic diseases and well as abdominal pain disorders will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.

More Information